Days after a surprise setback from its home country regulators, Shionogi & Co. Ltd.hopes a Chinese approval for its antiviral will help the Japanese drug maker in the second largest pharma market.
Partnered with Ping An, China’s major life insurance company, Shionogi has filed a new drug approval application with the China...







